Literature DB >> 31663301

Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity.

L Franza1,2, V Carusi1,2, S Altamura1,2, Al Caraffa3, C E Gallenga4, S K Kritas5, G Ronconi6, P Conti7, F Pandolfi1,2.   

Abstract

It is now well-known that interleukins (ILs) play a pivotal role in shaping innate immunity: inflammatory ILs are responsible for all innate aspects of immune response, from the very first vascular reactions to the chronic non-specific response to inflammation; while anti-inflammatory ILs are responsible for keeping adaptive immunity at bay. The interactions between ILs and adaptive immunity have been long considered secondary to the effects on the innate immune system, but in recent years it has appeared more clearly that IL direct interactions with adaptive immunity are extremely important both in physiologic and pathologic immune response. In the present review we analyze the role of inflammatory ILs (IL-1, IL-6, IL-33 and IL-37) on adaptive immunity and briefly discuss the possible therapeutic perspectives of IL-blockade in adaptive immunity disorders. Copyright 2019 Biolife Sas. www.biolifesas.org.

Entities:  

Keywords:  IL-37; IL-6; inflammatory cytokines; innate immunity

Mesh:

Substances:

Year:  2019        PMID: 31663301     DOI: 10.23812/Editorial

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  9 in total

Review 1.  Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren's Syndrome: Promising Inhibitory Effect of IL-37.

Authors:  Pio Conti; Luisa Stellin; Alesssandro Caraffa; Carla E Gallenga; Rhiannon Ross; Spyros K Kritas; Ilias Frydas; Ali Younes; Paolo Di Emidio; Gianpaolo Ronconi
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

2.  A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application.

Authors:  Carlo Contini; Carla Enrica Gallenga; Giampiero Neri; Martina Maritati; Pio Conti
Journal:  Med Hypotheses       Date:  2020-05-24       Impact factor: 1.538

3.  Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.

Authors:  Ester Del Duca; Paola Morelli; Luigi Bennardo; Cosimo Di Raimondo; Steven Paul Nisticò
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

Review 4.  Exploring the Effect of Probiotics, Prebiotics, and Postbiotics in Strengthening Immune Activity in the Elderly.

Authors:  Hiroyasu Akatsu
Journal:  Vaccines (Basel)       Date:  2021-02-08

Review 5.  Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases.

Authors:  Marcello Candelli; Laura Franza; Giulia Pignataro; Veronica Ojetti; Marcello Covino; Andrea Piccioni; Antonio Gasbarrini; Francesco Franceschi
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

6.  IL-37 Exerts Anti-Inflammatory Effects in Fetal Membranes of Spontaneous Preterm Birth via the NF-κB and IL-6/STAT3 Signaling Pathway.

Authors:  Lulu Wang; Zheng Liu; Dongni Huang; Yuxin Ran; Hanwen Zhang; Jie He; Nanlin Yin; Hongbo Qi
Journal:  Mediators Inflamm       Date:  2020-07-11       Impact factor: 4.711

7.  Acute Traumatic Brain Injury-Induced Neuroinflammatory Response and Neurovascular Disorders in the Brain.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Sudhanshu P Raikwar; Smita A Zaheer; Shankar S Iyer; Raghav Govindarajan; Premkumar Nattanmai Chandrasekaran; Casey Burton; Donald James; Asgar Zaheer
Journal:  Neurotox Res       Date:  2020-09-21       Impact factor: 3.911

Review 8.  Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review.

Authors:  Giovanni Tommaso Ranaldi; Emanuele Rocco Villani; Laura Franza
Journal:  Med Gas Res       Date:  2020 Jul-Sep

Review 9.  The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines.

Authors:  Rossella Cianci; Laura Franza; Maria Grazia Massaro; Raffaele Borriello; Francesco De Vito; Giovanni Gambassi
Journal:  Vaccines (Basel)       Date:  2020-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.